Lincoln Capital Corp’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $310K | Sell |
3,000
-1,000
| -25% | -$89.3K | 0.1% | 82 |
|
|
2026
Q1 | $287K | Buy |
+4,000
| New | +$308K | 0.11% | 75 |
|
|
2024
Q2 | – | Sell |
-4,140
| Closed | -$330K | – | 86 |
|
|
2024
Q1 | $330K | Buy |
4,140
+1,500
| +57% | +$115K | 0.14% | 55 |
|
|
2023
Q4 | $208K | Buy |
+2,640
| New | +$188K | 0.1% | 74 |
|
|
2023
Q3 | – | Sell |
-3,413
| Closed | -$236K | – | 75 |
|
|
2023
Q2 | $236K | Hold |
3,413
| – | – | 0.12% | 68 |
|
|
2023
Q1 | $254K | Sell |
3,413
-34,137
| -91% | -$2.86M | 0.15% | 56 |
|
|
2022
Q4 | $3.5M | Sell |
37,550
-601
| -2% | -$58K | 2.14% | 17 |
|
|
2022
Q3 | $3.64M | Sell |
38,151
-305
| -0.8% | -$30.2K | 2.44% | 14 |
|
|
2022
Q2 | $3.56M | Sell |
38,456
-30,028
| -44% | -$2.93M | 2.3% | 13 |
|
|
2022
Q1 | $6.93M | Sell |
68,484
-2,111
| -3% | -$222K | 3.62% | 9 |
|
|
2021
Q4 | $7.28M | Sell |
70,595
-107
| -0.2% | -$9.89K | 3.5% | 9 |
|
|
2021
Q3 | $6M | Sell |
70,702
-3,803
| -5% | -$319K | 3.22% | 10 |
|
|
2021
Q2 | $6.22M | Sell |
74,505
-1,831
| -2% | -$150K | 3.55% | 10 |
|
|
2021
Q1 | $5.74M | Buy |
76,336
+3,312
| +5% | +$241K | 3.58% | 10 |
|
|
2020
Q4 | $4.99M | Sell |
73,024
-3,187
| -4% | -$207K | 3.27% | 11 |
|
|
2020
Q3 | $4.45M | Buy |
76,211
+421
| +0.6% | +$26.2K | 3.26% | 8 |
|
|
2020
Q2 | $4.92M | Buy |
75,790
+2,665
| +4% | +$168K | 3.85% | 8 |
|
|
2020
Q1 | $4.34K | Buy |
73,125
+4,252
| +6% | +$284K | 1.94% | 11 |
|
|
2019
Q4 | $5.12M | Sell |
68,873
-13,054
| -16% | -$917K | 3.79% | 11 |
|
|
2019
Q3 | $5.17M | Buy |
81,927
+7,079
| +9% | +$419K | 4.37% | 8 |
|
|
2019
Q2 | $4.08M | Buy |
74,848
+99
| +0.1% | +$5.33K | 3.59% | 10 |
|
|
2019
Q1 | $4.03M | Buy |
74,749
+17,782
| +31% | +$1.1M | 3.65% | 10 |
|
|
2018
Q4 | $3.73M | Buy |
56,967
+29,064
| +104% | +$2.17M | 3.44% | 12 |
|
|
2018
Q3 | $2.2M | Buy |
27,903
+7,702
| +38% | +$551K | 1.82% | 21 |
|
|
2018
Q2 | $1.3M | Buy |
+20,201
| New | +$1.33M | 1.21% | 30 |
|
|
2017
Q4 | – | Sell |
-45,209
| Closed | -$3.68M | – | 51 |
|
|
2017
Q3 | $3.68M | Buy |
45,209
+21,205
| +88% | +$1.68M | 3.29% | 15 |
|
|
2017
Q2 | $1.93M | Sell |
24,004
-7,488
| -24% | -$591K | 1.71% | 25 |
|
|
2017
Q1 | $2.47M | Buy |
31,492
+8,636
| +38% | +$689K | 2.21% | 21 |
|
|
2016
Q4 | $1.8M | Buy |
+22,856
| New | +$1.85M | 1.73% | 25 |
|
Other funds holding CVS
Lincoln Capital Corp's CVS Position: Q2 2026 in Review
Lincoln Capital Corp reduced its CVS Health (CVS) stake by 25% in Q2 2026, selling an estimated $89.3K and leaving 3,000 shares worth $310K. The position accounts for 0.1% of the portfolio, ranked #82.
Lincoln Capital Corp first reported a position in CVS in Q4 2016 and has held it in 29 quarters since. The position peaked at $7.28M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Lincoln Capital Corp held 3,000 shares of CVS Health worth $310K as of Q2 2026.
- Lincoln Capital Corp sold 1,000 CVS Health shares in Q2 2026, an estimated $89.3K.
- CVS Health made up 0.1% of Lincoln Capital Corp's portfolio in Q2 2026, its #82 holding.
- Lincoln Capital Corp first reported a position in CVS Health in Q4 2016 and has held it in 29 quarters since.
- Lincoln Capital Corp's CVS Health position peaked at $7.28M in Q4 2021.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Lincoln Capital Corp's 13F filing for Q2 2026, filed 16 Jul 2026.